Skip to main content
Home Home
  • Learn
    • TraceLink
    • Opus Platform
    • Agile supply chain
    • Customers
    • Partners
    • TraceLink University
    • Support
    • About Us
  • Share
    • Catalog
    • Community
    • Events
Home Home

Network

  • All Networks
    • More coming soon
  • Team
  • Process
    • Log in
      • TraceLink Classic

        app.tracelink.com

Agile Supply Chain

  • The Agile Imperative
  • Insights
  • Resources
Back
  • PDF
  • Share
    • LinkedIn
    • Twitter
    • Facebook
    • Mail

Case Study: Value Drug Company | DSCSA Product Investigation—A Compliance Solution

October 28, 2019

Suspect and illegitimate product investigations can result in miscommunication with trade partners and record keeping problems—but Value Drug Company has the answer. Watch this FutureLink Nashville video and read the case study poster to learn how Value Drug Company is partnering with TraceLink to implement a formalized solution to standardize the process and provide the results of investigations to authorities when requested.

Value Drug Company Poster

Case Study,
DSCSA,
Healthcare & Pharmacies
More Serialization and Compliance Case Studies
Case Study: Sharp Packaging Services | EPCIS Connection Changes Post Go-Live
See how Sharp Packaging Services overcame EPCIS change management challenges in the pharma supply chain with TraceLink's help.
Case Study: CPL | The CMO Serialization Perspective—Utilizing a Standardized Approach for Efficient Partner Onboarding
See how contract manufacturer Contract Pharmaceuticals Limited implemented a 3-step process for smooth pharmaceutical partner onboarding.
Case Study: Noden Pharma | The Cost of Non-Compliance
See how global pharmaceuticals company Noden Pharma avoided the financial and operational risks of DSCSA noncompliance.
  • Legal & Trust
  • Contact Us
  • Careers
  • Sitemap

© TraceLink Inc. 2009-2021 All Rights Reserved

  • Log in
    • TraceLink Classic

      app.tracelink.com

  • Legal & Trust
  • Contact Us
  • Careers
  • Sitemap